A snapshot of consumer engagement in clinical trials in Australia: results of a national survey of clinical trial networks and research organisations

Abstract

Background Little is known about the extent, perceptions or experiences of consumers involved in clinical trials across Australia. The purpose of this National study was to better understand the activity and perceptions of clinical trial networks (CTNs), research co-ordinating centres and their consumers, around consumer involvement in clinical trials. Methods CTNs and research co-ordinating centres who were members of the Australian Clinical Trials Alliance (ACTA), and consumers involved in the activities of these organisations, were invited to participate in online surveys. Surveys were completed between April and September 2018. Results 80 respondents completed the surveys in full: 25 of 34 CTNs, 5 from 15 research co-ordinating centres, and included research investigators of 13 active trials, 10 completed trials. There were 27 consumer respondents. Consumers were involved in clinical trial activities across 19/25 (76%) of CTNs and 3/5 (60%) of research co-ordinating centres. Consumers were involved at all stages of the trial cycle. Despite this, only 8/30 (27%) of research organisations provided specific training to their employees or members on consumer involvement in research, and most did not have a specific policy or process relating to conducting consumer involvement in clinical trials. At the organisation level, barriers to consumer involvement in clinical trials included being unsure how to involve consumers effectively and systematically, difficulty in accessing consumers or lack of infrastructure and resources. At the consumer level, barriers included limited understanding of their roles, a lack of resources and training. Enablers included education, training and funding for both the research sector and for consumers. Almost all consumer respondents (25/27; 92%) would recommend the consumer role to other potential consumers, stating it was a valuable experience that led to knowledge exchange and learning about the research process. Conclusions Over the last few years, consumer involvement in clinical trials has increased in Australia, but the scope of involvement varies across different research organisations, and therapeutic areas. Consumer involvement in clinical trials is valued by most that do it, however, there are opportunities to further foster and strengthen ongoing partnerships, for example by providing practical advice for researchers on how to best engage and involve consumers.

Adopting recommendations for implementing patient involvement in cancer research: a funder’s approach

“…There has also been limited information [ 12 ] about involving patients in research funding bodies, except for the Innovative Medicines Initiative (IMI) Patient engagement Guide and the 600 case studies on Patient Engagement Initiatives published via PFMD Synapse [ 13 , 14 ]. The analysis of a survey in Australia [ 15 ] shows that “consumer involvement may occur only upon request from an external body i.e., research funders”, which also shows that funders (public or private) can play an active role in promoting PPI in research.…”

Die Beteiligung von Patient*innen an der Entwicklung von Leitlinien in der Klinischen Medizin. Ein selektiver Ländervergleich in narrativer Übersicht

“…Natürlich gibt es jenseits dieser beeindruckenden Dokumente und Strategien eine Realität, die sehr wohl Lücken und Probleme aufweist, wie eine kürzlich erschienene Publikation zeigt, die zu dem Ergebnis kommt, dass die Beteiligung von Patient*innen bzw. Konsument*innen bei der Entwicklung von LL in den letzten Jahren deutlich zugenommen hat und geschätzt wird [31]. Das tatsächliche Ausmaß der Beteiligung variiert jedoch nach Forschungsorganisation und Therapiebereich und ist noch zu optimieren (z.…”

Incorporating co‐design principles and social media strategies to enhance cross‐sectional online survey participation: The Birth Experience Study

“…Enablers to consumer involvement in research include early involvement of consumers and engagement of more than one consumer representative (Mckenzie et al, 2022) and consumer training for researchers (Ayton et al, 2022;.…”